Cargando…

Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie?

Two thirds of pediatric gliomas are classified as low-grade (LGG), while in adults only around 20% of gliomas are low-grade. However, these tumors do not only differ in their incidence but also in their location, behavior and, subsequently, treatment. Pediatric LGG constitute 65% of pilocytic astroc...

Descripción completa

Detalles Bibliográficos
Autores principales: Greuter, Ladina, Guzman, Raphael, Soleman, Jehuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624473/
https://www.ncbi.nlm.nih.gov/pubmed/34828788
http://dx.doi.org/10.3390/children8111075
_version_ 1784606182539788288
author Greuter, Ladina
Guzman, Raphael
Soleman, Jehuda
author_facet Greuter, Ladina
Guzman, Raphael
Soleman, Jehuda
author_sort Greuter, Ladina
collection PubMed
description Two thirds of pediatric gliomas are classified as low-grade (LGG), while in adults only around 20% of gliomas are low-grade. However, these tumors do not only differ in their incidence but also in their location, behavior and, subsequently, treatment. Pediatric LGG constitute 65% of pilocytic astrocytomas, while in adults the most commonly found histology is diffuse low-grade glioma (WHO II), which mostly occurs in eloquent regions of the brain, while its pediatric counterpart is frequently found in the infratentorial compartment. The different tumor locations require different skillsets from neurosurgeons. In adult LGG, a common practice is awake surgery, which is rarely performed on children. On the other hand, pediatric neurosurgeons are more commonly confronted with infratentorial tumors causing hydrocephalus, which more often require endoscopic or shunt procedures to restore the cerebrospinal fluid flow. In adult and pediatric LGG surgery, gross total excision is the primary treatment strategy. Only tumor recurrences or progression warrant adjuvant therapy with either chemo- or radiotherapy. In pediatric LGG, MEK inhibitors have shown promising initial results in treating recurrent LGG and several ongoing trials are investigating their role and safety. Moreover, predisposition syndromes, such as neurofibromatosis or tuberous sclerosis complex, can increase the risk of developing LGG in children, while in adults, usually no tumor growth in these syndromes is observed. In this review, we discuss and compare the differences between pediatric and adult LGG, emphasizing that pediatric LGG should not be approached and managed in the same way as adult LCG.
format Online
Article
Text
id pubmed-8624473
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86244732021-11-27 Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie? Greuter, Ladina Guzman, Raphael Soleman, Jehuda Children (Basel) Review Two thirds of pediatric gliomas are classified as low-grade (LGG), while in adults only around 20% of gliomas are low-grade. However, these tumors do not only differ in their incidence but also in their location, behavior and, subsequently, treatment. Pediatric LGG constitute 65% of pilocytic astrocytomas, while in adults the most commonly found histology is diffuse low-grade glioma (WHO II), which mostly occurs in eloquent regions of the brain, while its pediatric counterpart is frequently found in the infratentorial compartment. The different tumor locations require different skillsets from neurosurgeons. In adult LGG, a common practice is awake surgery, which is rarely performed on children. On the other hand, pediatric neurosurgeons are more commonly confronted with infratentorial tumors causing hydrocephalus, which more often require endoscopic or shunt procedures to restore the cerebrospinal fluid flow. In adult and pediatric LGG surgery, gross total excision is the primary treatment strategy. Only tumor recurrences or progression warrant adjuvant therapy with either chemo- or radiotherapy. In pediatric LGG, MEK inhibitors have shown promising initial results in treating recurrent LGG and several ongoing trials are investigating their role and safety. Moreover, predisposition syndromes, such as neurofibromatosis or tuberous sclerosis complex, can increase the risk of developing LGG in children, while in adults, usually no tumor growth in these syndromes is observed. In this review, we discuss and compare the differences between pediatric and adult LGG, emphasizing that pediatric LGG should not be approached and managed in the same way as adult LCG. MDPI 2021-11-22 /pmc/articles/PMC8624473/ /pubmed/34828788 http://dx.doi.org/10.3390/children8111075 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Greuter, Ladina
Guzman, Raphael
Soleman, Jehuda
Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie?
title Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie?
title_full Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie?
title_fullStr Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie?
title_full_unstemmed Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie?
title_short Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie?
title_sort pediatric and adult low-grade gliomas: where do the differences lie?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624473/
https://www.ncbi.nlm.nih.gov/pubmed/34828788
http://dx.doi.org/10.3390/children8111075
work_keys_str_mv AT greuterladina pediatricandadultlowgradegliomaswheredothedifferenceslie
AT guzmanraphael pediatricandadultlowgradegliomaswheredothedifferenceslie
AT solemanjehuda pediatricandadultlowgradegliomaswheredothedifferenceslie